Correlation Between Day One and Replimune
Can any of the company-specific risk be diversified away by investing in both Day One and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Day One and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Replimune.
Diversification Opportunities for Day One and Replimune
Good diversification
The 3 months correlation between Day and Replimune is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Day One i.e., Day One and Replimune go up and down completely randomly.
Pair Corralation between Day One and Replimune
Given the investment horizon of 90 days Day One is expected to generate 4.28 times less return on investment than Replimune. But when comparing it to its historical volatility, Day One Biopharmaceuticals is 1.79 times less risky than Replimune. It trades about 0.04 of its potential returns per unit of risk. Replimune Group is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 900.00 in Replimune Group on September 6, 2024 and sell it today you would earn a total of 417.00 from holding Replimune Group or generate 46.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Day One Biopharmaceuticals vs. Replimune Group
Performance |
Timeline |
Day One Biopharmaceu |
Replimune Group |
Day One and Replimune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Day One and Replimune
The main advantage of trading using opposite Day One and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |